NORTH AMERICA DNA SEQUENCING MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

NORTH AMERICA DNA SEQUENCING MARKET 2021-2028

Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research’s report has concluded that North America’s DNA sequencing market is likely to develop at a CAGR of 16.96% in the estimated years between 2021 and 2028.


Report scope can be customized per your requirements. Request For Customization

The countries analyzed in this market include:

•           The United States

•           Canada

The United States is home to a number of public and private companies that invest in personalized medicine and associated research activities. The rising adoption of developed technologies, government support, and favorable policies are primarily driving the demand for DNA sequencing in the country. Various government bodies, like the National Human Genome Research Institute (NHGRI), support research in the area of human genome sequencing, allocating substantial funds for this purpose. Further, these organizations support research studies on the legal, social, and ethical implications of genome research. All these factors are positively impacting the studied market’s growth.

For instance, Harvard Pilgrim Health Care and Illumina Inc announced signing an agreement in December 2020 to make the whole-genome sequencing (WGS) technology available to some of the Harvard Pilgrim members. The program is aimed to leverage this technology to support the faster diagnosis of genetic diseases in children. The sequencing technology is expected to eliminate the long, costly diagnostic processes and improve patient outcomes. In January 2020, Element Biosciences, a San Diego-based biotech company, raised $80 million to accelerate the development of its new platform for DNA sequencing. All these instances indicate that the United States market for DNA sequencing will progress significantly in the coming years.

Illumina Inc develops, manufactures, and distributes products and solutions having applications in multiple life science methods and procedures. The primary markets in which the company operates include life sciences and clinical genomics. Illumina offers a comprehensive range of products that help in multiple applications, like advanced disease research, drug development, and molecular tests. The company generates its major revenue from the sale of instruments and consumables it manufactures. These products are used to analyze the genome at all levels of complexity. The company also offers genotyping, whole-genome sequencing, and NIPT to conduct whole-genome sequencing & microarray projects. Founded in 1998, Illumina Inc is headquartered in San Diego, California.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. NORTH AMERICA DNA SEQUENCING MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE DNA SEQUENCING MARKET

2.2. KEY INSIGHTS

2.2.1. APPLICATIONS OF LIQUID BIOPSY

2.2.2. DEVELOPMENT IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY

2.2.3. NEXT GENERATION SEQUENCING

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. INDUSTRY COMPONENTS

2.5. KEY IMPACT ANALYSIS

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS AND PARTNERSHIPS

2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

2.8.3. ACQUISITIONS & MERGERS

2.8.4. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. PREVALENCE OF CANCER CASES

2.9.2. ADVANCEMENTS IN TECHNOLOGY

2.9.3. APPLICATIONS OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION

2.10. MARKET RESTRAINTS

2.10.1. CHALLENGES ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS

2.10.2. LIMITATIONS OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING

2.11. MARKET OPPORTUNITIES

2.11.1. EXTENSIVE RESEARCH AND DEVELOPMENT IN DNA SEQUENCING

2.11.2. GROWTH IN GENOME MAPPING PROGRAMS

3. NORTH AMERICA DNA SEQUENCING MARKET – BY PRODUCT

3.1. INSTRUMENTS & CONSUMABLES

3.1.1. INSTRUMENTS & CONSUMABLES TYPE

3.1.1.1. CONSUMABLES

3.1.1.2. INSTRUMENTS

3.1.2. INSTRUMENTS & CONSUMABLES PLATFORM

3.1.2.1. NGS (NEXT GENERATION SEQUENCING)

3.1.2.1.1. RNA SEQUENCING

3.1.2.1.2. TARGETED RESEQUENCING

3.1.2.1.3. WHOLE-EXOME SEQUENCING

3.1.2.1.4. WHOLE-GENOME SEQUENCING

3.1.2.1.5. CHIP SEQUENCING

3.1.2.1.6. DE NOVO SEQUENCING

3.1.2.1.7. METHYL SEQUENCING

3.1.2.2. SANGER

3.2. SEQUENCING SERVICES

3.3. BIOINFORMATICS

4. NORTH AMERICA DNA SEQUENCING MARKET – BY TECHNOLOGY

4.1. SEQUENCING BY SYNTHESIS

4.2. ION SEMICONDUCTOR SEQUENCING

4.3. CHAIN TERMINATION SEQUENCING

4.4. PYROSEQUENCING

4.5. SEQUENCING BY LIGATION (SBL)

4.6. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)

4.7. NANOPORE SEQUENCING

4.8. OTHER TECHNOLOGIES

5. NORTH AMERICA DNA SEQUENCING MARKET – BY APPLICATION

5.1. BIOMARKER DISCOVERY

5.2. DIAGNOSTICS

5.3. REPRODUCTIVE HEALTH

5.4. PERSONALIZED MEDICINE

5.5. DRUG DISCOVERY

5.6. AGRICULTURE & ANIMAL RESEARCH

5.7. FORENSICS

5.8. OTHER APPLICATIONS

6. NORTH AMERICA DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS

6.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES

6.2. PHARMACEUTICAL

6.3. BIOTECHNOLOGY COMPANIES

6.4. HOSPITALS & CLINICS

6.5. OTHER INDUSTRY VERTICALS

7. NORTH AMERICA DNA SEQUENCING MARKET – COUNTRY OUTLOOK

7.1. THE UNITED STATES

7.2. CANADA

8. COMPETITIVE LANDSCAPE

8.1. ADAPTIVE BIOTECHNOLOGIES INC

8.2. AGILENT TECHNOLOGIES INC

8.3. ASURAGEN INC

8.4. BGI GENOMICS

8.5. BIO-RAD LABORATORIES INC

8.6. DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)

8.7. EUROFINS SCIENTIFIC

8.8. F HOFFMANN-LA ROCHE

8.9. ILLUMINA INC

8.10. MERCK KGAA

8.11. PACIFIC BIOSCIENCES OF CALIFORNIA INC

8.12. PERKINELMER INC

8.13. SIEMENS HEALTHINEERS AG

8.14. SPIRAL GENETICS INC

8.15. THERMO FISHER SCIENTIFIC INC

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1. OBJECTIVES OF STUDY

9.1.2. SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1. PRIMARY DATA SOURCES

9.2.2. SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1. EVALUATION OF PROPOSED MARKET

9.3.2. IDENTIFICATION OF DATA SOURCES

9.3.3. ASSESSMENT OF MARKET DETERMINANTS

9.3.4. DATA COLLECTION

9.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       NORTH AMERICA DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       CONTRACTS AND PARTNERSHIPS

TABLE 4:       BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

TABLE 5:       ACQUISITIONS & MERGERS

TABLE 6:       NEW PRODUCT LAUNCHES

TABLE 7:       NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 8:       NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 9:       NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)

TABLE 10:     NORTH AMERICA NGS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 11:     NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 12:     NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 13:     NORTH AMERICA DNA SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

TABLE 14:     NORTH AMERICA DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     NORTH AMERICA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 2:     LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING

FIGURE 3:     NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 4:     NORTH AMERICA DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 5:     NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 6:     NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7:     NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)

FIGURE 8:     NORTH AMERICA NGS MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 9:     NORTH AMERICA NGS MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 10:  NORTH AMERICA NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 11:  NORTH AMERICA NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 12:  NORTH AMERICA NGS MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 13:  NORTH AMERICA NGS MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 14:  NORTH AMERICA NGS MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 15:  NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)

FIGURE 16:  NORTH AMERICA DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)

FIGURE 17:  NORTH AMERICA DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)

FIGURE 18:  NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)

FIGURE 19:  NORTH AMERICA DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)

FIGURE 20:  NORTH AMERICA DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 21:  NORTH AMERICA DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 22:  NORTH AMERICA DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 23:  NORTH AMERICA DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)

FIGURE 24:  NORTH AMERICA DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $ MILLION)

FIGURE 25:  NORTH AMERICA DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 26:  NORTH AMERICA DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 27:  NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 28:  NORTH AMERICA DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 29:  NORTH AMERICA DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 30:  NORTH AMERICA DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 31:  NORTH AMERICA DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32:  NORTH AMERICA DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 33:  NORTH AMERICA DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 34:  NORTH AMERICA DNA SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)

FIGURE 35:  NORTH AMERICA DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 36:  NORTH AMERICA DNA SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)

FIGURE 37:  NORTH AMERICA DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 38:  NORTH AMERICA DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)

FIGURE 39:  NORTH AMERICA DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 40:  NORTH AMERICA DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 41:  NORTH AMERICA DNA SEQUENCING MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

FIGURE 42:  THE UNITED STATES DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 43:  CANADA DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;